ATE539082T1 - OXAZINYLISOFLAVONOID COMPOUNDS, MEDICATIONS AND USES - Google Patents

OXAZINYLISOFLAVONOID COMPOUNDS, MEDICATIONS AND USES

Info

Publication number
ATE539082T1
ATE539082T1 AT08714321T AT08714321T ATE539082T1 AT E539082 T1 ATE539082 T1 AT E539082T1 AT 08714321 T AT08714321 T AT 08714321T AT 08714321 T AT08714321 T AT 08714321T AT E539082 T1 ATE539082 T1 AT E539082T1
Authority
AT
Austria
Prior art keywords
compounds
oxazinylisoflavonoid
medications
cardioprotective
oxidant
Prior art date
Application number
AT08714321T
Other languages
German (de)
Inventor
Andrew Heaton
Naresh Kumar
Catherine Walker
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007901105A external-priority patent/AU2007901105A0/en
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Application granted granted Critical
Publication of ATE539082T1 publication Critical patent/ATE539082T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents.
AT08714321T 2007-03-02 2008-02-29 OXAZINYLISOFLAVONOID COMPOUNDS, MEDICATIONS AND USES ATE539082T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007901105A AU2007901105A0 (en) 2007-03-02 Oxazinyl isoflavonoid compounds, medicaments and use
AU2007904434A AU2007904434A0 (en) 2007-08-17 Oxazinyl isoflavonoid compounds, medicaments and use
PCT/AU2008/000267 WO2008106715A1 (en) 2007-03-02 2008-02-29 Oxazinyl isoflavonoid compounds, medicaments and use

Publications (1)

Publication Number Publication Date
ATE539082T1 true ATE539082T1 (en) 2012-01-15

Family

ID=39737679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08714321T ATE539082T1 (en) 2007-03-02 2008-02-29 OXAZINYLISOFLAVONOID COMPOUNDS, MEDICATIONS AND USES

Country Status (7)

Country Link
US (1) US8367659B2 (en)
EP (1) EP2125831B1 (en)
JP (1) JP2010520156A (en)
AT (1) ATE539082T1 (en)
AU (1) AU2008222586A1 (en)
CA (1) CA2679580A1 (en)
WO (1) WO2008106715A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2738510A1 (en) * 2008-07-30 2010-02-04 Novogen Research Pty Ltd 6-substituted isoflavonoid compounds and uses thereof
US20100130598A1 (en) * 2008-10-22 2010-05-27 Novogen Research Pty Ltd. Methods for inducing programmed cell death
CN102924475B (en) * 2009-02-09 2014-10-29 沈阳药科大学 Novel oxazine compound and use of oxazine compound for anti-platelet aggregation
CN102924476A (en) * 2009-02-09 2013-02-13 沈阳药科大学 Novel oxazine compounds and application thereof
WO2011066606A1 (en) * 2009-12-01 2011-06-09 Novogen Research Pty Ltd Pyranoindole compounds and uses thereof
CN101948475B (en) * 2010-08-10 2014-06-25 沈阳药科大学 Isoflavone derivate-chromene (chroman) oxazines compound, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131193C (en) * 1965-01-28

Also Published As

Publication number Publication date
WO2008106715A1 (en) 2008-09-12
EP2125831A1 (en) 2009-12-02
EP2125831A4 (en) 2010-05-05
US8367659B2 (en) 2013-02-05
JP2010520156A (en) 2010-06-10
AU2008222586A1 (en) 2008-09-12
EP2125831B1 (en) 2011-12-28
US20110046722A1 (en) 2011-02-24
CA2679580A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
MY153915A (en) Organic compounds
ATE528989T1 (en) CRYSTALLINE SOLID RASAGILIN BASE
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
GEP20156230B (en) Forms of rifaximin and usage thereof
ATE526318T1 (en) FARNESOID-X RECEPTOR AGONISTS
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
JO3408B1 (en) Benzene sulfonamide thiazole and oxazole compounds
CY1110813T1 (en) CHEMICAL COMPOUNDS
NO20082413L (en) Microbiocidal composition
NO20090295L (en) Substituted heteroaryl derivatives
EA200900781A1 (en) 4-PHENYPYRANE-3,5-DIONA, 4-PHENYLTIOPYRANE-3,5-DIONA AND CYCLOHEXANTHRION, AS NEW HERBICIDES
JO2778B1 (en) Certain vehicles, installations and methods
CL2011000691A1 (en) Compounds derived from substituted nicotinamide; pharmaceutical composition that includes them; use for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
CL2007002890A1 (en) Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
CL2008002162A1 (en) Compounds derived from 3-benzoisoxazole-piperidine; pharmaceutical composition comprising said compounds; and its use for the treatment and / or prevention of cognitive disorders, drug addiction, depression, anxiety, among others.
EA201101116A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
TW200942524A (en) Novel aminomethyl benzene derivatives
CL2009000281A1 (en) Compounds derived from 5,6-dihydro-pyrrolo- [2,1-a] -isoquinolines and pyrrolo- [2,1-a] -isoquinolines; pharmaceutical composition comprising said compounds; and use for the treatment of fertility disorders.
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
EA201000258A1 (en) NEW HERBICIDES
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
TW200738627A (en) Trialkylsilyl-indoles
ECSP066883A (en) USEFUL HETEROARILAMINOPIRAZOL DERIVATIVES FOR THE TREATMENT OF DIABETES
ATE539082T1 (en) OXAZINYLISOFLAVONOID COMPOUNDS, MEDICATIONS AND USES